Loading SOLV detail
Loading ticker data...
Loading SOLV detail
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs.
It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I. V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
Chart data unavailable
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Solventum has a few good businesses, but the market is treating it as a complicated company. Its main parts are MedSurg, Dental, HIS, and a smaller Water / All Other. The thesis says the stock looks much cheaper than the value of the parts. The business could be worth about $166.6 per share based on SOTP analysis. The main idea is to keep MedSurg as the core business and see more value in the other parts on their own.
Solventum Corporation (NYSE: SOLV - Get Free Report) has earned an average recommendation of "Hold" from the thirteen brokerages that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and seven have issued a buy recommendation on the company. The
SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) -- SOLV Energy today highlighted its industry‑leading operations and maintenance (O&M) platform, with an O&M portfolio that exceeds 20 GW of utility-scale solar and storage capacity under management as of December 31, 2025, an increase of over 2 GW from the previous year. This scale reflects SOLV Energy's growing role supporting large, complex renewable energy portfolios across the United States, with a focus on operational discipline, safety, and lifecycle performance.
Investors interested in stocks from the Medical Services sector have probably already heard of Solventum (SOLV) and HealthEquity (HQY). But which of these two stocks presents investors with the better value opportunity right now?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
SOLV rides on strong segment demand, innovation push and cost savings plan, but tariffs and rising input costs cloud margin outlook.
SAN DIEGO, March 19, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (“SOLV” or the “Company”) (Nasdaq: MWH), a leading provider of infrastructure services to the power industry, today announced financial results for the fourth quarter and full year ended December 31, 2025. Financial Summary (in $ millions except percentages) Three Months Ended December 31, Twelve Months Ended December 31, 2025 2024 2025 2024 Revenue 794 441 2,490 1,848 Gross Profit 144 82 464 259 Gross Margin 18.1 % 18.5 % 18.6 % 14.0 % Net Income 1 36 10 149 10 Adjusted EBITDA 100 53 342 165 1) Net Income Attributable to Controlling Interest Financial and Recent Business Highlights Raised $552.5 million in net proceeds from initial public offering Repaid outstanding term loan and upsized revolver to $200 million Year-end 2025 backlog of $8 billion, an 87% increase over year-end 2024 Over 20 GW now under contract for O&M services “We closed 2025 with record financial performance that reflects the strength of our value proposition and the sustained demand for infrastructure services.
Solventum Corporation (SOLV) Presents at 2026 KeyBanc Capital Markets Healthcare Forum Transcript
SAN DIEGO, March 16, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (“SOLV” or the “Company”) (Nasdaq: MWH) plans to report fourth quarter and full year 2025 results on Thursday, March 19, 2026. Management will present results during a conference call at 8:30 a.m.
ST. PAUL, Minn., March 11, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in a virtual fireside chat at the KeyBanc Healthcare Forum on Wednesday, Mar. 18, 2026, beginning at approximately 10:30 a.m.
Shares of Solventum Corporation (NYSE: SOLV - Get Free Report) have earned an average rating of "Moderate Buy" from the twelve brokerages that are covering the stock, Marketbeat reports. Five research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 12 month price objective
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Solventum shares have traded sideways post-spin, as investors digest separation impacts, stranded costs, and recent capital allocation moves. Despite a $4.1B divestment and targeted $500M cost savings, 2025 results showed minimal free cash flow and only modest earnings growth. 2026 guidance calls for 2-3% organic sales growth and adjusted EPS of $6.50, but free cash flow remains weak at ~$200M.
Citigroup Inc. cut its stake in Solventum Corporation (NYSE: SOLV) by 37.1% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 169,090 shares of the company's stock after selling 99,558 shares during the quarter. Citigroup Inc. owned about 0.10% of
